2023-04-01 2024-03-31 false Capium Accounts Production 1.1 13294145 2023-04-01 2024-03-31 13294145 bus:AbridgedAccounts 2023-04-01 2024-03-31 13294145 bus:FRS102 2023-04-01 2024-03-31 13294145 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 13294145 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13294145 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13294145 2023-04-01 2024-03-31 13294145 2024-03-31 13294145 bus:RegisteredOffice 2023-04-01 2024-03-31 13294145 core:WithinOneYear 2024-03-31 13294145 core:AfterOneYear 2024-03-31 13294145 1 2023-04-01 2024-03-31 13294145 bus:Director1 2023-04-01 2024-03-31 13294145 bus:Director1 2024-03-31 13294145 bus:Director1 2022-04-01 2023-03-31 13294145 2022-04-01 13294145 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 13294145 2022-04-01 2023-03-31 13294145 2023-03-31 13294145 core:WithinOneYear 2023-03-31 13294145 core:AfterOneYear 2023-03-31 13294145 bus:EntityAccountantsOrAuditors 2022-04-01 2023-03-31 13294145 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 13294145 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 13294145 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 13294145 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 13294145 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 13294145 core:Non-currentFinancialInstruments 2024-03-31 13294145 core:Non-currentFinancialInstruments 2023-03-31 13294145 core:ShareCapital 2024-03-31 13294145 core:ShareCapital 2023-03-31 13294145 core:RetainedEarningsAccumulatedLosses 2024-03-31 13294145 core:RetainedEarningsAccumulatedLosses 2023-03-31 13294145 dpl:Item1 2023-04-01 13294145 dpl:Item1 2024-03-31 13294145 dpl:Item1 2022-04-01 13294145 dpl:Item1 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13294145


 

 

 

PHARMA SAVERS LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 April 2023

End date: 31 March 2024
 
 
Notes
 
2024
£
  2023
£
Current assets      
Stocks 7,355    7,125 
Debtors 2,069    617 
Cash at bank and in hand 3,666    3,988 
13,090    11,730 
Creditors: amount falling due within one year (31,418)   (7,050)
Net current assets (18,328)   4,680 
 
Total assets less current liabilities (18,328)   4,680 
Net assets (18,328)   4,680 
 

Capital and reserves
     
Called up share capital 1    1 
Profit and loss account (18,329)   4,679 
Shareholders' funds (18,328)   4,680 
 


For the accounting period the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 10 March 2025 and were signed by:


-------------------------------
Saeed Gheibi
Director
1
General Information
PHARMA SAVERS LIMITED is a private company, limited by shares, registered in England and Wales, registration number 13294145, registration address 143 PRAYLE GROVE, LONDON, NW2 1BD

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Cost of sales
Cost of sales comprises the invoiced value of goods and services purchased by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The companys liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted.
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2.

Staff Costs

2024
£
  2023
£
Wages and salaries 35,940    47,220 
35,940    47,220 
 
Average number of employees during the year Number   Number
Administration 1    1 
Sales 2    2 
 

3.

Average number of employees

Average number of employees during the year was 3 (2023 : 3).
2